Sagent Pharmaceuticals recalled three lots of Vecuronium Bromide for injection, a neuromuscular blocking agent used with general anesthesia to provide muscle relaxation or mechanical ventilation.
The voluntary nationwide recall stems from elevated levels of impurity detected during recent routine quality testing. No adverse events have been reported. However, elevated impurities have the potential to result in neuromuscular blockage in patients with renal failure.
Affected lots were distributed between January and May 2012.
More Articles on Anesthesia:
Anesthesia Business Consultants, iMDsoft Develop Cloud-Based Anesthesia EMR
Dr. Peter Sybert Elected President of California Society of Anesthesiologists
Study: Mount Sinai Anesthesiology Retraining Program Sees 70% Return to Practice
The voluntary nationwide recall stems from elevated levels of impurity detected during recent routine quality testing. No adverse events have been reported. However, elevated impurities have the potential to result in neuromuscular blockage in patients with renal failure.
Affected lots were distributed between January and May 2012.
More Articles on Anesthesia:
Anesthesia Business Consultants, iMDsoft Develop Cloud-Based Anesthesia EMR
Dr. Peter Sybert Elected President of California Society of Anesthesiologists
Study: Mount Sinai Anesthesiology Retraining Program Sees 70% Return to Practice